74 related articles for article (PubMed ID: 27007163)
1. ZNF217: An Oncogenic Transcription Factor and Potential Therapeutic Target for Multiple Human Cancers.
Wang Y; Ma C; Yang X; Gao J; Sun Z
Cancer Manag Res; 2024; 16():49-62. PubMed ID: 38259608
[TBL] [Abstract][Full Text] [Related]
2. SALL4-related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features.
Vienot A; Monnien F; Truntzer C; Mougey V; Bouard A; Pallandre JR; Molimard C; Loyon R; Asgarov K; Averous G; Ghiringhelli F; Bibeau F; Peixoto P; Borg C
Mol Oncol; 2023 Jul; 17(7):1356-1378. PubMed ID: 36587397
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cyclin D3 expression in malignancy patients: a meta-analysis.
Wang B; Wang Z; Han L; Gong S; Wang Y; He Z; Feng Y; Yang Z
Cancer Cell Int; 2019; 19():158. PubMed ID: 31198407
[TBL] [Abstract][Full Text] [Related]
4. SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts.
Kroemer M; Spehner L; Mercier-Letondal P; Boullerot L; Kim S; Jary M; Galaine J; Picard E; Ferrand C; Nguyen T; Larosa F; Adotévi O; Godet Y; Borg C
Oncoimmunology; 2018; 7(4):e1412030. PubMed ID: 29632725
[No Abstract] [Full Text] [Related]
5. SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer.
Matsumoto Y; Itou J; Sato F; Toi M
Cancer Med; 2018 Feb; 7(2):454-462. PubMed ID: 29356399
[TBL] [Abstract][Full Text] [Related]
6. SALL4 promotes glycolysis and chromatin remodeling via modulating HP1α-Glut1 pathway.
Kim J; Xu S; Xiong L; Yu L; Fu X; Xu Y
Oncogene; 2017 Nov; 36(46):6472-6479. PubMed ID: 28759035
[TBL] [Abstract][Full Text] [Related]
7. Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis.
Nicolè L; Sanavia T; Veronese N; Cappellesso R; Luchini C; Dabrilli P; Fassina A
Oncotarget; 2017 Apr; 8(14):22968-22979. PubMed ID: 28160555
[TBL] [Abstract][Full Text] [Related]
8. SALL4 promotes gastric cancer progression through activating CD44 expression.
Yuan X; Zhang X; Zhang W; Liang W; Zhang P; Shi H; Zhang B; Shao M; Yan Y; Qian H; Xu W
Oncogenesis; 2016 Nov; 5(11):e268. PubMed ID: 27819668
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics approach to infer cancer therapeutic targets on chromosome 20q across tumor types.
Snijders AM; Mao JH
Adv Mod Oncol Res; 2016; 2(4):215-223. PubMed ID: 27642640
[TBL] [Abstract][Full Text] [Related]
10. The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.
Cohen PA; Donini CF; Nguyen NT; Lincet H; Vendrell JA
Oncotarget; 2015 Dec; 6(39):41566-81. PubMed ID: 26431164
[TBL] [Abstract][Full Text] [Related]
11. Amplification of zinc finger gene 217 (ZNF217) and cancer: when good fingers go bad.
Quinlan KG; Verger A; Yaswen P; Crossley M
Biochim Biophys Acta; 2007 Jun; 1775(2):333-40. PubMed ID: 17572303
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic protein SALL4 and ZNF217 as prognostic indicators in solid cancers: a meta‑analysis of individual studies.
Cheng J; Gao J; Shuai X; Tao K
Oncotarget; 2016 Apr; 7(17):24314-25. PubMed ID: 27007163
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of AMPK in human malignancies: A meta-analysis.
Cheng J; Shuai X; Gao J; Cai M; Wang G; Tao K
Oncotarget; 2016 Nov; 7(46):75739-75748. PubMed ID: 27716618
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
15. The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis.
Li JZ; Gao W; Ho WK; Lei WB; Wei WI; Chan JY; Wong TS
Chin J Cancer; 2016 Nov; 35(1):95. PubMed ID: 27852288
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
